scholarly journals A MISSED OPPORTUNITY FOR DEMENTIA PREVENTION? CURRENT CHALLENGES FOR EARLY DETECTION AND MODERN-DAY SOLUTIONS

Author(s):  
R. Isaacson ◽  
N. Saif

The path towards developing effective therapeutics to either cure or prevent the onset of Alzheimer’s disease (AD) and related neurodegenerative dementias has been plagued by challenges. Nevertheless, innovative treatments and clinical frameworks that represent our current understanding of the trajectory of disease may help to reduce morbidity, or delay symptom onset, for patients in the pre-dementia stages. Late-life AD dementia develops over an extended period, first as an asymptomatic phase referred to as preclinical AD, which affects an estimated 46 million people in the United States alone (1). Following preclinical AD is the first symptomatic phase known as mild cognitive impairment (MCI) due to AD. Collectively, both stages offer a unique chance for early intervention.

2020 ◽  
pp. 147797142095908
Author(s):  
Renford Reese

The Reintegration Academy was founded in 2009. It was the first program of its kind in the United States to bring a group of parolees to a college campus for an extended period for academic programming. Since its inception, the Reintegration Academy has collaborated with the California Department of Corrections and Rehabilitation’s Division of Adult Parole Operations to host nine cohorts and served 251 parolees. Division of Adult Parole Operations assists in recruiting, screening, and giving participants referrals to the program. The program immerses 35 participants in Academic Orientation, Life Skills, and Career Development modules for eight weeks. The Reintegration Academy has an 85% success rate of enrolling participants in college and/or placing them in gainful employment. This article is a reflective essay that concisely discusses the genesis of the program, integrates a review of literature on the challenges in re-entry, the program’s anatomy, and the outcomes of the program.


2021 ◽  
Vol 9 ◽  
Author(s):  
Xia Wu ◽  
Li Fan ◽  
Songqing Ke ◽  
Yangting He ◽  
Ke Zhang ◽  
...  

Objective: The aim of this study was to explore the longitudinal associations of stroke with cognitive impairment in older US adults.Method: The data used in this longitudinal analysis were extracted from the National Health and Aging Trends Study (NHATS) from 2011 to 2019. Univariate and multivariable Cox proportional hazards regression models were used to estimate the longitudinal association of stroke with cognitive impairment. The multivariable model was adjusted by demographic, physical, and mental characteristics, and the complex survey design of NHATS was taken into consideration.Results: A total of 7,052 participants with complete data were included. At the baseline, the weighted proportion of cognitive impairment was 19.37% (95% CI, 17.92–20.81%), and the weighted proportion of the history of stroke was 9.81% (95% CI, 8.90–10.72%). In univariate analysis, baseline stroke history was significantly associated with cognitive impairment in the future (hazard ratio, 1.746; 95% CI, 1.461–2.088), and the baseline cognitive impairment was significantly associated with future report of stroke (hazard ratio, 1.436; 95% CI, 1.088–1.896). In multivariable model, stroke was also significantly associated with cognitive impairment (hazard ratio, 1.241; 95% CI, 1.011–1.522); however, the reverse association was not significant (hazard ratio, 1.068; 95% CI, 0.788–1.447). After the data from proxy respondents were excluded, in the sensitive analyses, the results remained unchanged.Conclusion: Older adults in the United States who suffered strokes are more likely to develop cognitive impairment as a result in the future than those who have not had strokes. However, the reverse association did not hold. Furthermore, the study suggests that it is necessary to screen and take early intervention for cognitive impairment in stroke survivors and prevent the incidence of stroke by modifying risk factors in the general population with rapidly growing older US adults.


Author(s):  
Narinder Kumar Bhasin ◽  
Kamal Gulati

Fintech/TechFin/financial and banking sector achieved the new digital disruptions and transformation milestones in India, underlining the various opportunities in the last year, 2020, when the world was struggling with the COVID-19 pandemic, an extended period of lockdown, job loss, and unemployment. India has emerged as the fastest-growing second largest leading fintech hub in the world after the United States. This chapter will explain the various challenges faced in the year 2020 and opportunities for fintech in 2021. The chapter also explains the emerging technology trends and growth of finechs in India during the COVID pandemic.


Author(s):  
Priya Balasubramanian ◽  
Tamas Kiss ◽  
Stefano Tarantini ◽  
Ádám Nyúl-Tóth ◽  
Chetan Ahire ◽  
...  

Over two thirds of individuals aged 65 and older are obese or overweight in the United States. Epidemiological data show an association between the degree of adiposity and cognitive dysfunction in the elderly. In this review, the pathophysiological roles of microvascular mechanisms, including impaired endothelial function and neurovascular coupling responses, microvascular rarefaction and blood-brain barrier disruption in the genesis of cognitive impairment in geriatric obesity are considered. The potential contribution of adipose-derived factors and fundamental cellular and molecular mechanisms of senescence to exacerbated obesity-induced cerebromicrovascular impairment and cognitive decline in aging are discussed.


Author(s):  
Merike Lang ◽  
Mónica Rosselli ◽  
Maria T Greig ◽  
Valeria L Torres ◽  
Idaly Vélez-Uribe ◽  
...  

Abstract Objective To analyze (1) whether there are ethnic differences in the severity of depressive symptoms between groups of elders classified as cognitively normal (CN) or amnestic mild cognitive impairment (aMCI) and (2) the influence of depressive symptoms on specific cognitive performance by ethnicity across diagnoses, controlling for covariates. Methods 164 Hispanics residing in the United States (HAs) and European Americans (EAs) (100 women; Mage = 72.1, SD = 8.0) were diagnosed as either CN or aMCI. Depressive symptoms were measured with the Geriatric Depression Scale (GDS-15). Cognition was assessed using the Loewenstein-Acevedo Scales for Semantic Interference and Learning (semantic memory), Multilingual Naming Test (confrontation naming), and the Stroop Test (Color–Word condition; executive function). A 2 × 2 univariate ANCOVA as well as linear and logistic regressions explored differences in depressive symptoms among diagnostic and ethnic groups. Results Higher depression was seen in aMCI compared to the CN group for both ethnicities, after controlling for age, education, gender, and Mini-Mental State Examination score. Greater levels of depression also predicted lower scores in confrontation naming and semantic memory for only the EA group and marginally in scores of executive function for HA participants. GDS-15 scores of ≤ 4 also predicted less likelihood of aMCI diagnosis. Conclusions Severity of depressive symptoms was associated with greater cognitive impairment, independent of ethnicity. Significant results suggest detrimental effects of depression on clinical diagnoses most evidently for subjects from the EA group.


2003 ◽  
Vol 15 (S1) ◽  
pp. 277-281
Author(s):  
Peter Whitehouse

The development of new drugs to treat vascular dementia and other conditions in which cognitive impairment is due at least in part to vascular pathology will require future interaction among academic, industry, and government regulatory clinicians and scientists. This article offers the author's perspective on the positive involvement of the Food and Drug Administration in development of conceptual frameworks and practical approaches to treatment of conditions characterized by vascular burden of the brain.


Sign in / Sign up

Export Citation Format

Share Document